Net Cash Provided by (Used in) Investing Activities of HAEMONETICS CORP from 03 Apr 2010 to 28 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Summary
HAEMONETICS CORP quarterly and annual Net Cash Provided by (Used in) Investing Activities in USD history and change rate from 03 Apr 2010 to 28 Jun 2025.
  • HAEMONETICS CORP Net Cash Provided by (Used in) Investing Activities for the quarter ending 28 Jun 2025 was $33,000,000, a 76% increase year-over-year.
  • HAEMONETICS CORP annual Net Cash Provided by (Used in) Investing Activities for 2024 was $161,895,000, a 50% increase from 2023.
  • HAEMONETICS CORP annual Net Cash Provided by (Used in) Investing Activities for 2023 was $322,389,000, a 124% decline from 2022.
  • HAEMONETICS CORP annual Net Cash Provided by (Used in) Investing Activities for 2022 was $143,788,000, a 67% decline from 2021.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Investing Activities, Annual (USD)
Net Cash Provided by (Used in) Investing Activities, YoY Annual Change (%)

HAEMONETICS CORP Quarterly Net Cash Provided by (Used in) Investing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $33,000,000 +$106,197,000 +76% 30 Mar 2025 28 Jun 2025 10-Q 07 Aug 2025 2026 Q1
Q2 2024 $139,197,000 -$123,936,000 -812% 31 Mar 2024 29 Jun 2024 10-Q 07 Aug 2025 2026 Q1
Q2 2023 $15,261,000 +$42,953,000 +74% 02 Apr 2023 01 Jul 2023 10-Q 08 Aug 2024 2025 Q1
Q2 2022 $58,214,000 -$42,363,000 -267% 03 Apr 2022 02 Jul 2022 10-Q 08 Aug 2023 2024 Q1
Q2 2021 $15,851,000 +$8,045,000 +34% 04 Apr 2021 03 Jul 2021 10-Q 10 Aug 2022 2023 Q1
Q2 2020 $23,896,000 -$25,757,000 -1384% 29 Mar 2020 27 Jun 2020 10-Q 11 Aug 2021 2022 Q1
Q2 2019 $1,861,000 +$29,125,000 31 Mar 2019 29 Jun 2019 10-Q 04 Aug 2020 2021 Q1
Q2 2018 $27,264,000 -$23,524,000 -629% 01 Apr 2018 30 Jun 2018 10-Q 06 Aug 2019 2020 Q1
Q2 2017 $3,740,000 +$18,652,000 +83% 02 Apr 2017 01 Jul 2017 10-Q 07 Aug 2018 2019 Q1
Q2 2016 $22,392,000 +$4,738,000 +17% 03 Apr 2016 02 Jul 2016 10-Q 07 Aug 2017 2018 Q1
Q2 2015 $27,130,000 +$9,891,000 +27% 29 Mar 2015 27 Jun 2015 10-Q 01 Aug 2016 2017 Q1
Q2 2014 $37,021,000 -$1,374,000 -3.9% 30 Mar 2014 28 Jun 2014 10-Q 30 Jul 2015 2016 Q1
Q2 2013 $35,647,000 -$26,458,000 -288% 31 Mar 2013 29 Jun 2013 10-Q 31 Jul 2014 2015 Q1
Q2 2012 $9,189,000 +$2,593,000 +22% 01 Apr 2012 30 Jun 2012 10-Q 02 Aug 2013 2013 Q1
Q2 2011 $11,782,000 +$3,331,000 +22% 03 Apr 2011 02 Jul 2011 10-Q 08 Aug 2012 2012 Q1
Q2 2010 $15,113,000 04 Apr 2010 03 Jul 2010 10-Q 10 Aug 2011 2011 Q1

HAEMONETICS CORP Annual Net Cash Provided by (Used in) Investing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $161,895,000 +$160,494,000 +50% 31 Mar 2024 29 Mar 2025 10-K 21 May 2025 2025 FY
2023 $322,389,000 -$178,601,000 -124% 02 Apr 2023 30 Mar 2024 10-K 21 May 2025 2025 FY
2022 $143,788,000 -$57,443,000 -67% 03 Apr 2022 01 Apr 2023 10-K 21 May 2025 2025 FY
2021 $86,345,000 +$339,097,000 +80% 04 Apr 2021 02 Apr 2022 10-K 20 May 2024 2024 FY
2020 $425,442,000 -$368,266,000 -644% 29 Mar 2020 03 Apr 2021 10-K 22 May 2023 2023 FY
2019 $57,176,000 +$58,972,000 +51% 31 Mar 2019 28 Mar 2020 10-K 25 May 2022 2022 FY
2018 $116,148,000 -$53,107,000 -84% 01 Apr 2018 30 Mar 2019 10-K 26 May 2021 2021 FY
2017 $63,041,000 +$10,272,000 +14% 02 Apr 2017 31 Mar 2018 10-K 20 May 2020 2020 FY
2016 $73,313,000 +$31,455,000 +30% 03 Apr 2016 01 Apr 2017 10-K 22 May 2019 2019 FY
2015 $104,768,000 +$17,000,000 +14% 29 Mar 2015 02 Apr 2016 10-K 23 May 2018 2018 FY
2014 $121,768,000 -$15,938,000 -15% 30 Mar 2014 28 Mar 2015 10-K 24 May 2017 2017 FY
2013 $105,830,000 +$490,565,000 +82% 31 Mar 2013 29 Mar 2014 10-K 01 Jun 2016 2016 FY
2012 $596,395,000 -$544,199,000 -1043% 01 Apr 2012 30 Mar 2013 10-K 22 May 2015 2015 FY
2011 $52,196,000 -$638,000 -1.2% 03 Apr 2011 31 Mar 2012 10-K 22 May 2014 2013 FY
2010 $51,558,000 +$80,777,000 +61% 04 Apr 2010 02 Apr 2011 10-K 20 May 2013 2012 FY
2009 $132,335,000 29 Mar 2009 03 Apr 2010 10-K 22 May 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.